Announcements Trials

Browse Landscape

Phase

Status

Recruiting 18 Active not recruiting 13 Completed 5 Terminated 3 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Breast 2 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 1

Interventions

Docetaxel 33 Radiosurgery 22 Radiotherapy 21 Sunitinib 20 pembrolizumab 17 Gemcitabine 16 Cisplatin 16 Androgen Antagonists 15 enzalutamide 13 Nivolumab 13 Goserelin 12 Blood Specimen Collection 12 aldesleukin 11 Surveys and Questionnaires 11 Prednisone 11 Leuprolide 11 Cyclophosphamide 11 Abiraterone Acetate 11 Bevacizumab 10 bicalutamide 9 Multiparametric Magnetic Resonance Imaging 9 Carboplatin 9 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 Gonadotropin-Releasing Hormone 8 Filgrastim 8 Epirubicin 8 Chemotherapy, Adjuvant 8 Brachytherapy 8 toripalimab 7 tislelizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × X-Rays × Genitourinary × Clear all

NCT05481372 2022-08-01

PINPOINT Feasibility Study

Royal Marsden NHS Foundation Trust

Phase NA Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡